In contrast, Gascón-Ruiz et al. exhibited a negative correlation between PD-1+CD56brightCD16-NK and OS in NSCLC patients (n = 55) treated with various aPD-1/aPD-L1 monotherapies [150]. The gene discussed is PDCD1; the disease is non-small cell lung carcinoma.